扶桑薬品工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/01/31 | 2,194 | 2,209 | 2,176 | 2,209 | +19 | +0.9% | 14,700 |
| 2024/01/30 | 2,221 | 2,233 | 2,186 | 2,190 | -43 | -1.9% | 26,700 |
| 2024/01/29 | 2,232 | 2,255 | 2,223 | 2,233 | +11 | +0.5% | 17,400 |
| 2024/01/26 | 2,210 | 2,230 | 2,198 | 2,222 | +8 | +0.4% | 24,800 |
| 2024/01/25 | 2,188 | 2,216 | 2,188 | 2,214 | +13 | +0.6% | 19,700 |
| 2024/01/24 | 2,203 | 2,229 | 2,187 | 2,201 | -11 | -0.5% | 29,000 |
| 2024/01/23 | 2,219 | 2,222 | 2,188 | 2,212 | -12 | -0.5% | 35,500 |
| 2024/01/22 | 2,235 | 2,260 | 2,212 | 2,224 | -8 | -0.4% | 36,900 |
| 2024/01/19 | 2,257 | 2,269 | 2,215 | 2,232 | -11 | -0.5% | 46,500 |
| 2024/01/18 | 2,218 | 2,252 | 2,209 | 2,243 | +32 | +1.4% | 48,600 |
| 2024/01/17 | 2,144 | 2,268 | 2,144 | 2,211 | +58 | +2.7% | 122,700 |
| 2024/01/16 | 2,120 | 2,170 | 2,080 | 2,153 | +29 | +1.4% | 149,400 |
| 2024/01/15 | 1,970 | 2,130 | 1,967 | 2,124 | +154 | +7.8% | 326,800 |
| 2024/01/12 | 1,997 | 1,997 | 1,960 | 1,970 | -26 | -1.3% | 39,800 |
| 2024/01/11 | 1,986 | 1,997 | 1,978 | 1,996 | +21 | +1.1% | 43,200 |
| 2024/01/10 | 1,956 | 1,995 | 1,955 | 1,975 | +22 | +1.1% | 41,200 |
| 2024/01/09 | 1,925 | 1,956 | 1,925 | 1,953 | +33 | +1.7% | 40,500 |
| 2024/01/05 | 1,903 | 1,921 | 1,903 | 1,920 | +11 | +0.6% | 27,400 |
| 2024/01/04 | 1,898 | 1,909 | 1,888 | 1,909 | +18 | +1% | 23,100 |
| 2023/12/29 | 1,891 | 1,895 | 1,884 | 1,891 | +1 | +0.1% | 14,700 |
| 2023/12/28 | 1,874 | 1,890 | 1,870 | 1,890 | +23 | +1.2% | 22,000 |
| 2023/12/27 | 1,855 | 1,867 | 1,855 | 1,867 | +12 | +0.6% | 31,300 |
| 2023/12/26 | 1,851 | 1,860 | 1,851 | 1,855 | ±0 | ±0% | 15,500 |
| 2023/12/25 | 1,869 | 1,872 | 1,848 | 1,855 | -8 | -0.4% | 21,800 |
| 2023/12/22 | 1,853 | 1,866 | 1,853 | 1,863 | +11 | +0.6% | 19,500 |
| 2023/12/21 | 1,860 | 1,863 | 1,851 | 1,852 | -12 | -0.6% | 20,000 |
| 2023/12/20 | 1,870 | 1,876 | 1,863 | 1,864 | -9 | -0.5% | 33,300 |
| 2023/12/19 | 1,872 | 1,875 | 1,867 | 1,873 | +3 | +0.2% | 32,800 |
| 2023/12/18 | 1,854 | 1,873 | 1,841 | 1,870 | +6 | +0.3% | 39,300 |
| 2023/12/15 | 1,865 | 1,865 | 1,847 | 1,864 | +2 | +0.1% | 29,300 |
| 2023/12/14 | 1,880 | 1,880 | 1,857 | 1,862 | -11 | -0.6% | 28,300 |
| 2023/12/13 | 1,872 | 1,880 | 1,862 | 1,873 | +1 | +0.1% | 17,800 |
| 2023/12/12 | 1,881 | 1,886 | 1,865 | 1,872 | -13 | -0.7% | 26,800 |
| 2023/12/11 | 1,886 | 1,887 | 1,876 | 1,885 | +1 | +0.1% | 18,400 |
| 2023/12/08 | 1,893 | 1,895 | 1,872 | 1,884 | -11 | -0.6% | 45,700 |
| 2023/12/07 | 1,905 | 1,905 | 1,895 | 1,895 | -13 | -0.7% | 14,600 |
| 2023/12/06 | 1,905 | 1,910 | 1,899 | 1,908 | +13 | +0.7% | 28,500 |
| 2023/12/05 | 1,908 | 1,914 | 1,895 | 1,895 | -14 | -0.7% | 22,800 |
| 2023/12/04 | 1,909 | 1,913 | 1,900 | 1,909 | -3 | -0.2% | 22,000 |
| 2023/12/01 | 1,909 | 1,921 | 1,908 | 1,912 | +5 | +0.3% | 30,600 |
| 2023/11/30 | 1,902 | 1,910 | 1,891 | 1,907 | +4 | +0.2% | 27,100 |
| 2023/11/29 | 1,912 | 1,914 | 1,903 | 1,903 | -11 | -0.6% | 14,900 |
| 2023/11/28 | 1,906 | 1,914 | 1,902 | 1,914 | +8 | +0.4% | 26,900 |
| 2023/11/27 | 1,909 | 1,913 | 1,902 | 1,906 | ±0 | ±0% | 18,700 |
| 2023/11/24 | 1,899 | 1,906 | 1,895 | 1,906 | +14 | +0.7% | 26,400 |
| 2023/11/22 | 1,890 | 1,903 | 1,890 | 1,892 | +2 | +0.1% | 12,800 |
| 2023/11/21 | 1,886 | 1,897 | 1,885 | 1,890 | -3 | -0.2% | 18,400 |
| 2023/11/20 | 1,901 | 1,909 | 1,892 | 1,893 | -12 | -0.6% | 28,300 |
| 2023/11/17 | 1,885 | 1,908 | 1,881 | 1,905 | +19 | +1% | 23,900 |
| 2023/11/16 | 1,900 | 1,901 | 1,885 | 1,886 | -10 | -0.5% | 26,800 |
201～
250
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ハートシード | 145,000円 | +154.1% | - | 0.00% | - | 7.10倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム
